Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(21)
DRUG(3)
DIETARY_SUPPLEMENT(2)
OTHER(1)
laboratory biomarker analysis
5 trials
early_phase_1phase_1phase_2
mayo-clinic
questionnaire administration
4 trials
early_phase_1not_applicablephase_2
academic-and-community-cancer-research-united, mayo-clinic
quality-of-life assessment
3 trials
early_phase_1phase_1phase_2
mayo-clinic
auranofin
2 trials
early_phase_1phase_2
mayo-clinic
Ketoconazole
1 trial
early_phase_1
mayo-clinic
white wine
1 trial
not_applicable
academic-and-community-cancer-research-united
serum-derived bovine immunoglobulin protein isolate
1 trial
phase_2
mayo-clinic
menadione topical lotion
1 trial
not_applicable
mayo-clinic

+9 more interventions

17 unique interventions4 categories

Analytics

Trial Phases

Phase 12
Phase 22

Trial Status

Completed8
Terminated1

Role Distribution

Principal Investigator6
Other Roles3
PI Rate67%

Activity Timeline

Clinical Trials (9)

NCT04236154Phase 1Completed
"Prescribing" Exercise to Cancer Patients At High-Risk for Falls
Cancer
PrincipalinvestigatorStart date: 2020-09-03
NCT03471364Early Phase 1Completed
Ketoconazole in Treating Participants With Ongoing EGFR Inhibitor-Induced Rash
Malignant Neoplasm
PrincipalinvestigatorStart date: 2018-09-25
NCT03456700Phase 2Terminated
Auranofin and Sirolimus in Treating Participants With Ovarian Cancer
Ovarian Serous TumorRecurrent Ovarian Carcinoma
PrincipalinvestigatorStart date: 2018-03-30
NCT03122886Not ApplicableCompleted
Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin
Advanced Malignant Neoplasm
PrincipalinvestigatorStart date: 2017-07-14
NCT02598726Phase 1Completed
Curcumin and Piperine in Reducing Inflammation for Ureteral Stent-Induced Symptoms in Patients With Cancer
Bladder SpasmMalignant NeoplasmPain+1 more
PrincipalinvestigatorStart date: 2016-03-01
NCT01867606Phase 2Completed
Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery
Female Reproductive Cancer
PrincipalinvestigatorStart date: 2013-10-04
NCT01747798Early Phase 1Completed
Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Recurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity Cancer
StudychairStart date: 2012-11-02
NCT01393821Not ApplicableCompleted
Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab
Dermatologic ComplicationsMalignant NeoplasmPain
StudychairStart date: 2012-01-23
NCT00936728Not ApplicableCompleted
White Wine or Nutritional Supplement in Improving Appetite in Patients With Cancer
Unspecified Adult Solid Tumor, Protocol Specific
StudychairStart date: 2009-07-01

Research Network

Collaboration Network

8 collaborators·8 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Amber L. Isley, M.D.

Mayo Clinic

Related
1 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol Specific

Worked with same sponsors:

Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)
Collaborated on 1 trial
Similarity Score14%

Tom R. Fitch, M.D.

Mayo Clinic

Related
3 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol Specific

Worked with same sponsors:

Academic and Community Cancer Research UnitedMayo Clinic+1 more
Collaborated on 1 trial
Similarity Score14%

Elizabeth J. Cathcart-Rake, M.D.

Mayo Clinic

Related
1 trials

Shared therapeutic areas:

Cancer

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)
Collaborated on 1 trial
Similarity Score14%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol SpecificCancerDermatologic Complications+1 more

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)
Similarity Score9%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

CancerUnspecified Adult Solid Tumor, Protocol Specific

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Gisèle Pickering

University Hospital, Clermont-Ferrand

Related
34 trials

Shared therapeutic areas:

PainCancer
Similarity Score5%

Mike Royal, MD

Sorrento Therapeutics, Inc.

Related
19 trials

Shared therapeutic areas:

CancerPain
Similarity Score5%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Cancer
Similarity Score2%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Cancer
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (9)

Showing 9 of 9 trials

NCT04236154Phase 1PrincipalInvestigator

"Prescribing" Exercise to Cancer Patients At High-Risk for Falls

Cancer
Completed
NCT03471364Early Phase 1PrincipalInvestigator

Ketoconazole in Treating Participants With Ongoing EGFR Inhibitor-Induced Rash

Malignant Neoplasm
Completed
NCT03456700Phase 2PrincipalInvestigator

Auranofin and Sirolimus in Treating Participants With Ovarian Cancer

Ovarian Serous TumorRecurrent Ovarian Carcinoma
Terminated
NCT03122886Not ApplicablePrincipalInvestigator

Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin

Advanced Malignant Neoplasm
Completed
NCT02598726Phase 1PrincipalInvestigator

Curcumin and Piperine in Reducing Inflammation for Ureteral Stent-Induced Symptoms in Patients With Cancer

Bladder SpasmMalignant NeoplasmPain+1 more
Completed
NCT01867606Phase 2PrincipalInvestigator

Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery

Female Reproductive Cancer
Completed
NCT01747798Early Phase 1StudyChair

Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity Cancer
Completed
NCT01393821Not ApplicableStudyChair

Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab

Dermatologic ComplicationsMalignant NeoplasmPain
Completed
NCT00936728Not ApplicableStudyChair

White Wine or Nutritional Supplement in Improving Appetite in Patients With Cancer

Unspecified Adult Solid Tumor, Protocol Specific
Completed

All 9 trials loaded